Table 2.
Participant Characteristics Relevant to Outcome Determination after Treatment Exposure
| Parameter | iNO (N=98) | iEPO (N=103) | P-value |
|---|---|---|---|
| dDuration of treatment, hours | 45.7 (33.1, 102.6) | 46.6 (30.4, 83.6) | 0.43a |
| Delayed Chest closure | 15 (15.3%) | 7 (6.8%) | 0.053b |
| eECMO Present on ICU arrival | 17 (17.4%)) | 16 (15.5%) | 0.73b |
| fECMO placed within 72 hours | 7 (7.1%) | 6 (5.8%) | 0.70c |
| gPRBC transfusion, Units | 2 (0, 4) | 2 (1, 4) | 0.62a |
p-Value Key:
a
Wilcoxon
b
Chi-Square
c
Equal Variance t-test.
d
In the per-protocol population, iEPO group had n=102, with median duration of 46.6 hours (IQR, 30.7, 83.6) after LT before discontinuation of iEPO.
e
ECMO placement between ICU arrival and 72-hours after LT.
f
ECMO placement in the operating room during LT that continued into the intensive care unit
g
Transfusion data missing for 1 iNO patient
ECMO, Extracorporeal membrane oxygenation; ICU, Intensive care unit; PRBC, Packed red blood cells